Applied Genetic Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AGTC and buy or sell other stocks, ETFs, and their options commission-free!About AGTC
Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology.
CEODavid A. Fellows
CEODavid A. Fellows
Employees—
Employees—
HeadquartersAlachua, Florida
HeadquartersAlachua, Florida
Founded1999
Founded1999
Employees—
Employees—
AGTC Key Statistics
Market cap26.62M
Market cap26.62M
Price-Earnings ratio-0.28
Price-Earnings ratio-0.28
Dividend yield—
Dividend yield—
Average volume1.38M
Average volume1.38M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.83
52 Week high$2.83
52 Week low$0.2303
52 Week low$0.2303
Stock Snapshot
As of today, Applied Genetic Technologies(AGTC) shares are valued at $0.39. The company's market cap stands at 26.62M, with a P/E ratio of -0.28.
During the trading day, Applied Genetic Technologies(AGTC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.38M.
The stock's 52-week range extends from a low of $0.23 to a high of $2.83.
The stock's 52-week range extends from a low of $0.23 to a high of $2.83.
People also own
Based on the portfolios of people who own AGTC. This list is generated using Robinhood data, and it’s not a recommendation.